Comment & Analysis
Pharma stocks face pressure on tariff and pricing fronts
key takeaways. Pharmaceutical products are covered by the US-EU trade deal, which helped ease concerns for the sector. However, they are excluded from the recent 39% US tariff imposed on Swiss imports. We expect a separate update on pharmaceutical tariffs The US healthcare system faces political reform, with changes to…
Continue Reading
Subscribe to unlock the full article and access premium financial content.
Click here to read the full story: Lombard Odier